Procter & Gamble (NYSE:PG) Stock Sold by Rep. David Taylor

Representative David Taylor (Republican-Ohio) recently sold shares of Procter & Gamble Company (The) (NYSE:PG). In a filing disclosed on October 15th, the Representative disclosed that they had sold between $1,001 and $15,000 in Procter & Gamble stock on October 12th. The trade occurred in the Representative’s “DAVID TAYLOR TRUST > SCHWAB JOINT BROKERAGE #1 (HOME GROWN)” account.

Representative David Taylor also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Fifth Third Bancorp (NASDAQ:FITB) on 10/9/2026.
• Purchased $1,001 – $15,000 in shares of RPM International (NYSE:RPM) on 10/9/2026.
• Purchased $1,001 – $15,000 in shares of AT&T (NYSE:T) on 10/9/2026.
• Sold $1,001 – $15,000 in shares of Marathon Petroleum (NYSE:MPC) on 9/22/2026.
• Purchased $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 9/22/2026.
• Purchased $1,001 – $15,000 in shares of Amgen (NASDAQ:AMGN) on 9/22/2026.
• Purchased $1,001 – $15,000 in shares of Installed Building Products (NYSE:IBP) on 9/8/2026.
• Purchased $1,001 – $15,000 in shares of Procter & Gamble (NYSE:PG) on 9/8/2026.
• Sold $1,001 – $15,000 in shares of Amgen (NASDAQ:AMGN) on 8/26/2026.
• Sold $1,001 – $15,000 in shares of Vertex Pharmaceuticals (NASDAQ:VRTX) on 8/26/2026.

Procter & Gamble Stock Up 1.4%

Shares of PG stock traded up $2.17 during midday trading on Friday, reaching $159.25. 13,532,344 shares of the stock were exchanged, compared to its average volume of 8,482,994. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $167.25. The company’s 50 day moving average is $146.88 and its two-hundred day moving average is $146.52. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43. The firm has a market cap of $369.89 billion, a PE ratio of 24.06, a price-to-earnings-growth ratio of 3.90 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last released its earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.02. The company had revenue of $21.20 billion during the quarter, compared to analysts’ expectations of $21.38 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%. The firm’s revenue for the quarter was up 1.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, equities research analysts predict that Procter & Gamble Company will post 6.98 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be given a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble’s payout ratio is presently 65.71%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of PG. Baxter Bros Inc. acquired a new position in shares of Procter & Gamble in the 2nd quarter valued at $12,381,000. Empowered Funds LLC acquired a new stake in Procter & Gamble during the 2nd quarter worth $53,549,000. Bank of America Corp DE acquired a new stake in Procter & Gamble during the 2nd quarter worth $3,850,628,000. Rokos Capital Management LLP acquired a new stake in Procter & Gamble during the 1st quarter worth $29,914,000. Finally, State Street Corp lifted its position in Procter & Gamble by 1.0% in the second quarter. State Street Corp now owns 102,216,308 shares of the company’s stock valued at $14,988,999,000 after acquiring an additional 965,461 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

PG has been the subject of a number of recent research reports. TD Cowen reissued a “hold” rating and set a $150.00 price target on shares of Procter & Gamble in a research report on Wednesday, September 30th. Royal Bank Of Canada cut their price objective on shares of Procter & Gamble from $167.00 to $166.00 and set an “outperform” rating on the stock in a report on Tuesday, October 6th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a research note on Monday, September 21st. Jefferies Financial Group lifted their target price on shares of Procter & Gamble from $177.00 to $179.00 and gave the company a “buy” rating in a report on Friday, June 26th. Finally, Citigroup boosted their price target on Procter & Gamble from $170.00 to $180.00 and gave the stock a “buy” rating in a research report on Friday, October 9th. Fourteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus target price of $162.20.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Improving U.S. sales outlook: UBS maintained its Buy rating and $172 price target, saying better U.S. sales momentum could help P&G outperform expectations when it reports before the market opens on October 22. Procter & Gamble’s improving US sales trends set up a favorable first-quarter report, UBS says
• Positive Sentiment: Defensive dividend appeal: Recent investor-focused coverage highlighted P&G’s 70-year record of dividend increases. That long history, combined with demand for everyday household products, may support the stock as investors seek stable income and less exposure to technology-sector volatility. Procter & Gamble Has Raised Its Dividend for 70 Years
• Neutral Sentiment: Upcoming earnings are the key catalyst: Analysts expect modest revenue growth for fiscal first-quarter 2027, while the company’s latest reported quarter showed revenue growth of 1.5% year over year and earnings that narrowly exceeded consensus. Investors will focus on organic sales, pricing, volumes and updated full-year guidance. Procter & Gamble Set to Release Earnings
• Negative Sentiment: Profit risks remain: Earnings previews warn that rising costs could pressure margins and cause quarterly earnings to decline, reducing the likelihood of a significant earnings beat. P&G’s valuation—about 24 times earnings based on the supplied data—also leaves less room for disappointment. Procter & Gamble Pre-Q1 Earnings
• Negative Sentiment: Some institutional selling: ETFs were reported as net sellers of PG, a modest near-term technical headwind, though this flow does not necessarily signal a change in the company’s long-term fundamentals. ETFs Are Net Sellers of Procter & Gamble

Insider Buying and Selling

In other Procter & Gamble news, CAO Matthew Janzaruk sold 359 shares of the company’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $145.24, for a total value of $52,141.16. Following the completion of the transaction, the chief accounting officer directly owned 1,271 shares of the company’s stock, valued at $184,600.04. This represents a 22.02% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Andre Schulten sold 3,914 shares of the firm’s stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $145.34, for a total value of $568,860.76. Following the sale, the chief financial officer owned 65,618 shares of the company’s stock, valued at $9,536,920.12. This represents a 5.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 15,135 shares of company stock valued at $2,189,970 over the last ninety days. Company insiders own 0.23% of the company’s stock.

About Representative Taylor

David Taylor (Republican Party) is a member of the U.S. House, representing Ohio’s 2nd Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Taylor (Republican Party) ran for election to the U.S. House to represent Ohio’s 2nd Congressional District. He won in the general election on November 5, 2024.

David Taylor graduated from Amelia High School. Taylor earned degrees from Miami University (Ohio) and the University of Dayton School of Law. Taylor’s career experience includes working as an attorney and as a businessman at Sardinia Ready Mix, Inc.

About Procter & Gamble

The Procter & Gamble Company (NYSE: PG) is a consumer products company that develops, manufactures and markets branded products used in households and personal care routines. Its portfolio includes products in categories such as beauty, grooming, health care, fabric and home care, and family care.

Major brands associated with Procter & Gamble include Pampers, Tide, Gillette, Head & Shoulders, Pantene, Oral-B, Crest, Olay, Old Spice, Febreze, Mr. Clean, Swiffer and Bounty. The company sells its products through retailers, e-commerce platforms and other distribution channels.

Founded in Cincinnati, Ohio, in 1837 by William Procter and James Gamble, the company has grown into a global consumer goods business serving customers in markets around the world.